Literature DB >> 17072675

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.

J Esquivel1, R Sticca, P Sugarbaker, E Levine, T D Yan, R Alexander, D Baratti, D Bartlett, R Barone, P Barrios, S Bieligk, P Bretcha-Boix, C K Chang, F Chu, Q Chu, S Daniel, E de Bree, M Deraco, L Dominguez-Parra, D Elias, R Flynn, J Foster, A Garofalo, F N Gilly, O Glehen, A Gomez-Portilla, L Gonzalez-Bayon, S Gonzalez-Moreno, M Goodman, V Gushchin, N Hanna, J Hartmann, L Harrison, R Hoefer, J Kane, D Kecmanovic, S Kelley, J Kuhn, J Lamont, J Lange, B Li, B Loggie, H Mahteme, G Mann, R Martin, R A Misih, B Moran, D Morris, L Onate-Ocana, N Petrelli, G Philippe, J Pingpank, A Pitroff, P Piso, M Quinones, L Riley, L Rutstein, S Saha, S Alrawi, A Sardi, S Schneebaum, P Shen, D Shibata, J Spellman, A Stojadinovic, J Stewart, J Torres-Melero, T Tuttle, V Verwaal, J Villar, N Wilkinson, R Younan, H Zeh, F Zoetmulder, G Sebbag.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17072675     DOI： 10.1245/s10434-006-9185-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  109 in total

1.  Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies.

Authors:  Pedro Bretcha-Boix; Jose Farré-Alegre; Manuel Sureda; Carlos Dussan; Juan José Pérez Ruixo; Antonio Brugarolas Masllorens
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Ingmar Königsrainer
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

3.  Colorectal Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

4.  Case records of the Massachusetts General Hospital. Case 19-2010. A 35-year-old man with adenocarcinoma of the cecum.

Authors:  David P Ryan; Jeffrey A Engelman; Cristina R Ferrone; Dushyant V Sahani; Mikhail Lisovsky
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

5.  Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy.

Authors:  Cherif Boutros; Ponandai Somasundar; N Joseph Espat
Journal:  World J Surg Oncol       Date:  2010-08-20       Impact factor: 2.754

6.  Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer.

Authors:  Toshihiro Kanda; Syohei Fukuda; Naotaka Fukui; Yu Ohkubo; Tomoko Kazumoto; Yoshihiro Saito; Ayataka Ishikawa; Masafumi Kurosumi; Yukio Kageyama; Yasuhisa Fujii; Kazunori Kihara
Journal:  Int J Clin Oncol       Date:  2016-01-11       Impact factor: 3.402

7.  Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model.

Authors:  Wim Bouquet; Steven Deleye; Steven Staelens; Lieselotte De Smet; Nancy Van Damme; Isabelle Debergh; Wim P Ceelen; Filip De Vos; Jean Paul Remon; Chris Vervaet
Journal:  Pharm Res       Date:  2011-03-18       Impact factor: 4.200

8.  Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.

Authors:  Suma L Sangisetty; Thomas J Miner
Journal:  World J Gastrointest Surg       Date:  2012-04-27

9.  [Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].

Authors:  G Glockzin; N Ghali; S A Lang; A Agha; H J Schlitt; P Piso
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

Review 10.  Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.

Authors:  Simon Binder; Andrew L Lewis; J-Matthias Löhr; Michael Keese
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.